Apomorphine Hydrochloride

盐酸阿扑吗啡

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameApomorphine Hydrochloride
Drug Alias Name盐酸阿扑吗啡水合物Apomorphine hydrochloride hydrate阿扑吗啡盐酸盐TaluvianUprima +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine receptors agonists
TargetsDopamine receptors
Therapy Area/IndicationsPoisoningErectile DysfunctionHallucinations +[6] 
Global Approved IndicationsPoisoningErectile DysfunctionParkinson Disease
Approved Indications in ChinaPoisoning
Original Approved Country/TerritoryMainland China
Original Approved Date1996/01/01
Country/TerritoryBelgiumCanadaUnited States +[13] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesStada Arzneimittel Ag
China Registration ClassN/A

Develop Information

Active CompaniesPaladin Labs Canadian Holding IncUniversity of LiegeSumitomo Pharma America Inc +[9] 
Inactive CompaniesKyowa Kirin Co LtdUniversity Medical Center GroningenOregon Health And Science University +[9] 
Active IndicationsPoisoningErectile DysfunctionConsciousness Disorders +[4] 
Inactive IndicationsHallucinationsBrain Injuries

Other Information

ATC CodeG04BE07N04BC07
Related LinksWikipediaDrugBankKEGG